Maximizing the benefits of antiretroviral therapy for key affected populations

被引:14
|
作者
Grubb, Ian R. [1 ]
Beckham, Sarah W. [2 ]
Kazatchkine, Michel [3 ]
Thomas, Ruth M. [4 ]
Albers, Eliot R. [5 ]
Cabral, Mauro [6 ]
Lange, Joep [7 ]
Vella, Stefano [8 ]
Kurian, Manoj [9 ]
Beyrer, Chris [2 ]
机构
[1] Johns Hopkins Univ, Ctr Publ Hlth & Human Rights, Baltimore, MD USA
[2] Johns Hopkins Univ, Dept Epidemiol, Baltimore, MD USA
[3] UN, Geneva, Switzerland
[4] Global Network Sex Work Projects, Edinburgh, Midlothian, Scotland
[5] Int Network People Who Use Drugs, London, England
[6] Global Act Trans Equal, Buenos Aires, DF, Argentina
[7] Amsterdam Inst Global Hlth & Dev, Amsterdam, Netherlands
[8] Ist Super Sanita, Dept Therapeut HIV Hepatitis & Global Hlth, I-00161 Rome, Italy
[9] Int AIDS Soc, Geneva, Switzerland
关键词
treatment; HIV/AIDS; human rights; FEMALE SEX WORKERS; MIDDLE-INCOME COUNTRIES; INJECTION-DRUG USERS; HIV INCIDENCE; TRANSGENDER PERSONS; RISK BEHAVIORS; CARE SERVICES; UNITED-STATES; MEN; PREVENTION;
D O I
10.7448/IAS.17.1.19320
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Introduction: Scientific research has demonstrated the clinical benefits of earlier initiation of antiretroviral treatment (ART), and that ART can markedly reduce HIV transmission to sexual partners. Ensuring universal access to ART for those who need it has long been a core principle of the HIV response, and extending the benefits of ART to key populations is critical to increasing the impact of ART and the overall effectiveness of the HIV response. However, this can only be achieved through coordinated efforts to address political, social, legal and economic barriers that key populations face in accessing HIV services. Discussion: Recent analyses show that HIV prevalence levels among key populations are far higher than among the general population, and they experience a range of biological and behavioural factors, and social, legal and economic barriers that increase their vulnerability to HIV and have resulted in alarmingly low ART coverage. World Health Organization 2014 consolidated guidance on HIV among key populations offers the potential for increased access to ART by key populations, following the same principles as for the general adult population. However, it should not be assumed that key populations will achieve greater access to ART unless stigma, discrimination and punitive laws, policies and practices that limit access to ART and other HIV interventions in many countries are addressed. Conclusions: Rights-based approaches and investments in critical enablers, such as supportive legal and policy environments, are essential to enable wider access to ART and other HIV interventions for key populations. The primary objective of ART should always be to treat the person living with HIV; prevention is an important, additional benefit. ART should be provided only with informed consent. The preventive benefits of treatment must not be used as a pretext for failure to provide other necessary HIV programming for key populations, including comprehensive harm reduction and other prevention interventions tailored to meet the needs of key populations. An end to AIDS is only possible if we overcome the barriers of criminalization, stigma and discrimination that remain key drivers of the HIV epidemics among key populations.
引用
收藏
页数:8
相关论文
共 50 条
  • [1] Challenges in expanding access to antiretroviral therapy for key affected populations
    Kamarulzaman, Adeeba
    [J]. PUBLIC HEALTH ACTION, 2014, 4 (02): : 73 - 73
  • [2] Hormone therapy: Maximizing the benefits
    Heikkinen, Jorma
    [J]. GYNECOLOGICAL ENDOCRINOLOGY, 2006, 22 (03) : 160 - 162
  • [3] THE UNREALIZED BENEFITS OF ANTIRETROVIRAL THERAPY
    COHN, JA
    [J]. PEDIATRIC AIDS AND HIV INFECTION-FETUS TO ADOLESCENT, 1995, 6 (05): : 295 - 300
  • [4] Assessing the benefits of antiretroviral therapy
    Gulick, RM
    [J]. ANNALS OF INTERNAL MEDICINE, 2000, 133 (06) : 471 - 473
  • [5] Resisting resistance: Maximizing the durability of antiretroviral therapy
    Condra, JH
    [J]. ANNALS OF INTERNAL MEDICINE, 1998, 128 (11) : 951 - 954
  • [7] Massive Benefits of Antiretroviral Therapy in Africa
    Vermund, Sten H.
    [J]. JOURNAL OF INFECTIOUS DISEASES, 2014, 209 (04): : 483 - 485
  • [8] Benefits and risks of rapid initiation of antiretroviral therapy
    Ford, Nathan
    Migone, Chantal
    Calmy, Alexandra
    Kerschberger, Bernhard
    Kanters, Steve
    Nsanzimana, Sabin
    Mills, Edward J.
    Meintjes, Graeme
    Vitoria, Marco
    Doherty, Meg
    Shubber, Zara
    [J]. AIDS, 2018, 32 (01) : 17 - 23
  • [9] The Survival Benefits of Antiretroviral Therapy in South Africa
    April, Michael D.
    Wood, Robin
    Berkowitz, Bethany K.
    Paltiel, A. David
    Anglaret, Xavier
    Losina, Elena
    Freedberg, Kenneth A.
    Walensky, Rochelle P.
    [J]. JOURNAL OF INFECTIOUS DISEASES, 2014, 209 (04): : 491 - 499
  • [10] ELECTROCONVULSIVE THERAPY: MAXIMIZING BENEFITS AND MINIMIZING ADVERSE EFFECTS
    Weiss, A.
    Waite, S.
    Hussain, S.
    [J]. AUSTRALIAN AND NEW ZEALAND JOURNAL OF PSYCHIATRY, 2018, 52 : 160 - 160